Yuke Shu
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A selective BRG1 inhibitor targeting bromodomain sensitizes hepatocellular carcinoma to chemoradiotherapy by disrupting the DNA damage response.
Journal: Chinese medical journal
Published: January 12, 2026
In vivo generation of fibrolytic macrophages via LNP-CSF1 mRNA attenuates liver fibrosis.
Journal: Journal of nanobiotechnology
Published: December 12, 2025
Arginase 1 promotes hepatic lipogenesis by regulating ERK2/PPARγ signaling in a non-canonical manner.
Journal: Nature communications
Published: December 19, 2024
Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy.
Journal: Chinese medical journal
Published: May 30, 2023
HDAC3 Controls Liver Homeostasis More by Facilitating Deoxyribonucleic Acid Damage Repair than by Regulating Transcription in Hepatocytes.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: September 20, 2022
Increased Small Ubiquitin-like Modifier-Activating Enzyme SAE1 Promotes Hepatocellular Carcinoma by Enhancing mTOR SUMOylation.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: May 11, 2022
Mettl14-Mediated m6A Modification Facilitates Liver Regeneration by Maintaining Endoplasmic Reticulum Homeostasis.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 26, 2020
Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion.
Journal: Hepatology (Baltimore, Md.)
Published: June 23, 2020
Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
Journal: Clinical science (London, England : 1979)
Published: March 02, 2020
Last Updated: 09/26/2026